Onderneming Chemomab Therapeutics Ltd.
Aandelen
CMMB
US16385C1045
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,74 USD | +0,65% | +15,64% | +45,10% |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Adi Mor
CEO | Chief Executive Officer | 43 | 22-09-11 |
Sigal Fattal
DFI | Director of Finance/CFO | 53 | 01-01-20 |
Chief Tech/Sci/R&D Officer | 56 | 14-11-22 | |
Ilan Vaknin
CTO | Chief Tech/Sci/R&D Officer | - | 12-08-22 |
Jack Lawler
CTO | Chief Tech/Sci/R&D Officer | - | 04-01-22 |
Barbara Lindheim
IRC | Investor Relations Contact | - | - |
Sharon Hashmueli
LAW | General Counsel | - | 01-01-16 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Neil Cohen
BRD | Director/Board Member | 60 | 01-04-20 |
Nissim Darvish
CHM | Chairman | 59 | 16-03-21 |
Claude Nicaise
BRD | Director/Board Member | 71 | 16-03-21 |
Alan Moses
BRD | Director/Board Member | 76 | 16-03-21 |
Adi Mor
CEO | Chief Executive Officer | 43 | 22-09-11 |
Jill Quigley
BRD | Director/Board Member | 48 | 21-06-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 20 | 14 204 735 | 705 422 ( 4,966 %) | 0 | 4,966 % |
Bedrijfsgegevens
Chemomab Therapeutics Ltd.
Kiryat Atidim Building 7
6158002, Tel Aviv
+972 77 331 0156
http://www.chemomab.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+45,10% | 10,51 mln. | |
+8,96% | 105 mld. | |
-1,43% | 104 mld. | |
+4,40% | 22,94 mld. | |
-12,15% | 22,34 mld. | |
-4,36% | 19,25 mld. | |
-39,98% | 17,08 mld. | |
-10,04% | 16,96 mld. | |
+38,61% | 12,63 mld. | |
+313,59% | 8,49 mld. |
- Beurs
- Aandelen
- Koers CMMB
- Onderneming Chemomab Therapeutics Ltd.